Clinical trial for Bronchopulmonary Dysplasia
Official title Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
ClinicalTrials.gov ID: NCT06373289
What this study is testing
- What it's testing
- The study aims to find out whether adjusting oxygen amounts can improve outcomes for infants with bronchopulmonary dysplasia and pulmonary hypertension.
- Who it's for
- Preterm infants who have bronchopulmonary dysplasia and pulmonary hypertension.
- What's involved
- Participants will receive varying oxygen levels as part of their care, with regular monitoring and health checks to track progress.
- Time commitment
- The study lasts until the infant reaches a set age or milestone, with scheduled visits and tests during that period.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 5. Healthy volunteers may be eligible.
You may be able to join if
- Between 22w 0/7d and 31w 6/7d gestation at birth
- Diagnosed with echocardiographic pulmonary hypertension (1) \>20% flow of blood across the PDA from the pulmonary to arterial circulation, (2)...
- Receiving supplemental oxygen
- Have mature retinas
You likely can't join if
- Major congenital anomalies
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- New Haven, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 5 months. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; New Haven, Connecticut, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.